Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe study page now indicates that recruitment has ended and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan area is updated to include an Intervention/Treatment label, and the revision note updates to v3.6.0.SummaryDifference0.3%

- Check10 days agoChange DetectedThe page’s revision label changed from v3.5.4 to v3.5.5, indicating a behind-the-scenes update to the site’s software or layout rather than a change to study content or details.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4. This indicates a new deployment of the site, typically reflecting minor fixes or updates rather than changes to visible content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s revision/version indicator for the ClinicalTrials.gov site has been bumped from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check89 days agoChange DetectedFrontend revision updated: v3.5.0 deployed and v3.4.3 removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.